Discussion about this post

User's avatar
novictim's avatar

Well done. Good article. But you missed one other "trick" for Ibrexafungerp. What if Ibrexafungerp is far less likely to cause fetal harm than azoles? Have you looked at the research, not just the drug insert? Because that is what we will have here in a few years or less as data comes in. Animal models showed that normal treatment dose did NOT cause fetal harm. A FIVE TIMES dose did. Now, think. At normal dosing, azoles reek havoc on early fetal development and viability.

You are welcome.

Expand full comment
1 more comment...

No posts